홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dimethylformamide → HCID 89690493, 화합물

HRID 1481874
노트
인쇄 미리보기

반응식

HRID 1481874 반응식
[Cl:1][C:2]1[CH:10]=[C:9]([N:11]2[CH2:16][CH2:15][N:14]([C:17]3[CH:22]=[C:21]([CH3:23])[CH:20]=[CH:19][C:18]=3[CH3:24])[CH2:13][CH2:12]2)[C:8]([N+:25]([O-:27])=[O:26])=[CH:7][C:3]=1[C:4](O)=[O:5].CN(C)C=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.[CH3:66][N:67]([CH2:69][C:70]1[CH:71]=[C:72]([CH:75]=[CH:76][CH:77]=1)[CH2:73][NH2:74])[CH3:68]>O.C(OCC)(=O)C>[Cl:1][C:2]1[CH:10]=[C:9]([N:11]2[CH2:16][CH2:15][N:14]([C:17]3[CH:22]=[C:21]([CH3:23])[CH:20]=[CH:19][C:18]=3[CH3:24])[CH2:13][CH2:12]2)[C:8]([N+:25]([O-:27])=[O:26])=[CH:7][C:3]=1[C:4]([NH:74][CH2:73][C:72]1[CH:75]=[CH:76][CH:77]=[C:70]([CH2:69][N:67]([CH3:68])[CH3:66])[CH:71]=1)=[O:5]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 6228DimethylformamideHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 162280701-(3-(Aminomethyl)phenyl)-N,N-dimethylmethanamineHCID 89690453HCID 89690453, 화합물

생성물 1

HCID 89690493
HCID 89690493, 화합물
수율 97.6%

시약·촉매·용매 2

HCID 962Water용매HCID 8857Ethyl Acetate용매

실험 절차

In a 40 ml scintillation vial equipped with a magnetic stir bar and a nitrogen inlet, the 2-chloro-4-[4-(2,5-dimethyl-phenyl)-piperazin-1-yl]-5-nitro-benzoic acid 12b (157.90 mg, 0.41 mmol) was taken up in clean, dry N,N-dimethylformamide (5.00 ml, 64.57 mmol) and the reaction mixture was stirred under nitrogen at room temperature until all solids had gone into solution. To the reaction was then added the HATU (184.80 mg, 0.49 mmol) followed by the N,N-diisopropylethylamine (0.14 ml, 0.80 mmol) and the mixture was stirred until all solids had gone into solution. The 3-dimethylaminomethyl-benzylamine (86.50 mg, 0.53 mmol) was then added to the reaction solution and the reaction was allowed to stir at room temperature overnight. The reaction was diluted with 15 ml of water and 15 ml of ethyl acetate. The layers were then separated and the product was extracted from the aqueous using ethyl acetate (3×20 ml). The organic phases were combined, washed with brine (1×25 ml) and with saturated aqueous lithium chloride solution (2×25 ml). The product solution was then dried over Na2SO4; the solution was then decanted and the solvent was removed under reduced pressure. The crude product, 2-chloro-N-(3-dimethylaminomethyl-benzyl)-4-[4-(2,5-dimethyl-phenyl)-piperazin-1-yl]-5-nitro-benzamide 13a (214.40 mg, 0.40 mmol), was isolated as an amber oil and was carried on without further purification. LCMS (m/e)=537 (M+H).

후처리

  1. customIn a 40 ml scintillation vial equipped with a magnetic stir bar and a nitrogen inlet
  2. stirringthe mixture was stirred until all solids
  3. stirringto stir at room temperature overnight
  4. customThe layers were then separated
  5. extractionthe product was extracted from the
  6. washwashed with brine (1×25 ml) and with saturated aqueous lithium chloride solution (2×25 ml)
  7. dry with materialThe product solution was then dried over Na2SO4
  8. customthe solution was then decanted
  9. customthe solvent was removed under reduced pressure

출처 및 근거

ORD 기록
ord-70e2269eb8cc4a53b08561ea8832061f
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09409897B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트